Growing Demand for Higher Protein Content Driving Newborn Calf Serum Market Growth

 

Newborn calf serum is derived from blood collected from newborn calves less than 20 days old through cardiac puncture. It is a rich protein diet that provides growth factors, hormones, attachment factors and other nutrients required for in vitro cell culture. Newborn calf serum is commonly used as a supplement in cell and tissue culture media as it supports the growth of several cell lines. The Global Newborn Calf Serum Market Size is estimated to be valued at US$ 730 million in 2023 and is expected to exhibit a CAGR of 9.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The growing demand for products with higher protein content is the major trend driving the growth of the newborn calf serum market. Newborn calf serum contains higher concentration of growth factors, carrier proteins, attachment factors and other nutrients as compared to adult bovine serum. This makes it a preferred choice for culturing several types of mammalian cells. Researchers have found newborn calf serum to effectively support growth of various cell lines including neuronal, endothelial and hepatic cells. It enables consistent cell growth and proliferation. This increasing preference towards newborn calf serum for its superior performance is expected to boost the demand over the forecast period.

Segment Analysis
The global newborn calf serum market is dominated by the calf serum segment. Calf serum finds wide applications in research owing to its properties like balanced nutrition, easy availability, and ability to support growth of various cell types. It contains abundant growth factors and other essential nutrients required for cell culture. Moreover, calf serum is affordable and readily available compared to other serum types.

Key Takeaways
The global newborn calf serum market is expected to witness high growth over the forecast period of 2024 to 2031.

Regional analysis: North America currently dominates the market owing to large presence of biopharmaceutical and biotechnology industries in the US and Canada. However, Asia Pacific is expected to grow at the fastest pace during the forecast period due to rising investments in life sciences research in China, India, and other emerging economies.

Key players: Key players operating in the newborn calf serum market are Thermo Fisher Scientific, Merck KGaA, GE Healthcare, TCS Biosciences Ltd., HiMedia Laboratories, Bio-Techne, Rocky Mountain Biologicals, Atlanta Biologicals, Inc., Biological Industries, Zhejiang Tianhang Biotechnology Co., Ltd. Thermo Fisher Scientific is a prominent player in the market owing to its wide portfolio of cell culture products including serum, media, and reagents. The company has a strong global footprint and continues to strengthen its market position through strategic collaborations and new product launches.

Get More Insights Here: https://www.newswirestats.com/newborn-calf-serum-market-size-share-and-growth-forecast-2023-2030/

Related Reports: https://whotimes.com/beyond-dna-exploring-the-frontier-of-creation-through-the-lens-of-synthetic-biology/